SCHEMBL4128915

SCHEMBL4128915

CC(C)(C)OC(=O)Nc1ccc(Cl)cc1C(=O)c1cccc2c1OCCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
RXFP1 Q9HBX9 1/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRE P78334 1/20 0.39
GABRA6 Q16445 1/20 0.39
GABRG1 Q8N1C3 1/20 0.39
GABRG3 Q99928 1/20 0.39
GABRQ Q9UN88 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4124853 0.84 MAPT (0.46) MAPTGABRPGABRDGABRA1GABRB1
SCHEMBL4118772 0.81 FDFT1 (0.44) HSP90AA1HSP90AB1EGFRALDH1A1NPC1
SCHEMBL7949833 0.79 MRGPRX1 (0.46) RXFP1CTNNB1WNT3AALDH1A1KDM4E
SCHEMBL30317135 0.79 MRGPRX1 (0.46) RXFP1CTNNB1WNT3AALDH1A1KDM4E
SCHEMBL4124169 0.76 GAA (0.52) MAPTHSP90AA1HSP90AB1GABRPGABRD
SCHEMBL4117584 0.75 RECQL (0.55) MAPTEGFRCTNNB1WNT3AALDH1A1
SCHEMBL29259910 0.73 KDM4E (0.63) HSP90AA1HSP90AB1ALDH1A1KDM4EHSD17B10
SCHEMBL24269577 0.72 ATR (0.53) HSP90AA1HSP90AB1RXFP1CYP1A2CYP2C19
SCHEMBL5214590 0.71 CTNNB1 (0.55) MAPTCTNNB1WNT3AALDH1A1KDM4E
SCHEMBL8258036 0.71 SLC10A6 (0.50) MAPTALDH1A1MAPK1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR MAPT 4428/4885HSP90AA1 4018/4885HSP90AB1 3883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.